Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Glioblastoma 1Advanced Lung Cancer 1Advanced Cancer 1

Interventions

pembrolizumab 1029Carboplatin 966Paclitaxel 941Gemcitabine 798Cisplatin 754Docetaxel 697Bevacizumab 638Nivolumab 519Pemetrexed 507Capecitabine 475Cyclophosphamide 468Fluorouracil 424Dexamethasone 409Rituximab 391Oxaliplatin 351Injections 344Trastuzumab 313atezolizumab 311Cetuximab 291Leucovorin 288Irinotecan 269130-nm albumin-bound paclitaxel 255Prednisone 250Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 215durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Chlorogenic Acid × Clear all
NCT03751592 2018-11-26

Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1/2 Unknown
144 enrolled
Thoracic

Advanced Lung Cancer

NCT02245204 2018-11-21

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
8 enrolled

Advanced Cancer

NCT02728349 2018-11-01

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
26 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡